Indian Firms May Want To Slow March Into China

New markets are opening up for Indian firms and China appears to be the flavor of the season, but gaining a strong foothold there is not expected to be even "half as easy" as in the US.

China and India flags
• Source: Shutterstock

Indian pharmaceutical firms are flocking to China, after the Asian giant opened its doors to generics and unveiled a raft of favorable regulatory reforms including accepting foreign clinical trial data to support new drug approvals.

More than half a dozen front-line Indian firms including Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd.,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Outlook Archive

More from Outlook